Dana Ascherman, MD, Appointed Chief of the Division of Rheumatology and Clinical Immunology
January 23, 2021
Effective as of December 1, 2020, Dana Ascherman, MD, has been appointed to chief of the Division of Rheumatology and Clinical Immunology.
An international leader in the field of autoimmune diseases and idiopathic inflammatory myopathy, Dr. Ascherman is a talented translational researcher and highly respected clinician. He has skillfully led the Division since May 2020, when he was appointed Interim Chief.
About Dr. Ascherman
Dr. Ascherman returned to the University of Pittsburgh in 2018 as professor of Medicine after previously serving as assistant and associate professor of Medicine from 1998-2010.
Dr. Ascherman is an accomplished R01- and Merit Review-funded translational investigator, with expertise ranging from basic and pre-clinical science to biomarker discovery. Dr. Ascherman’s research focuses on the immunopathogenesis of idiopathic inflammatory myopathy as well as autoimmune interstitial lung disease, with particular emphasis on the relationship between innate and adaptive immune responses in these diseases.
He has published more than 50 original peer-reviewed manuscripts as well as numerous invited reviews and book chapters, has served on multiple NIH and foundation grant review committees, and has held a number of editorial roles.
Although his clinical interests expand to the broader spectrum of autoimmune disorders, Dr. Ascherman has worked with members of the Pulmonary Division to develop the interdisciplinary Autoimmune Interstitial Lung Disease Clinic.
